Literature DB >> 17442950

Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells.

Srinivas Mummidi1, Lisa M Adams, Scott E VanCompernolle, Mrunal Kalkonde, Jose F Camargo, Hemant Kulkarni, Adam S Bellinger, Gregory Bonello, Hiromi Tagoh, Seema S Ahuja, Derya Unutmaz, Sunil K Ahuja.   

Abstract

Surface levels of CCR5 on memory CD4(+) T cells influence HIV-1/AIDS susceptibility. Alternative promoter usage results in the generation of CCR5 mRNA isoforms that differ based on whether they contain or lack the untranslated exon 1. The impact of exon 1-containing transcripts on CCR5 surface expression is unknown. In this study, we show that the increased cell surface expression of CCR5 on primary T cells is associated with selective enrichment of exon 1-containing transcripts. The promoter that drives exon 1-containing transcripts is highly active in primary human T cells but not in transformed T cell lines. The transcription factors Oct-1 and -2 inhibit and enhance, respectively, the expression of exon 1-containing transcripts and CCR5 surface levels. However, polymorphisms at homologous octamer-binding sites in the CCR5 promoter of nonhuman primates abrogate the binding of these transcription factors. These results identify exon 1-containing transcripts, and the cis-trans factors that regulate the expression levels of these mRNA isoforms as key parameters that affect CCR5 surface expression levels, and by extension, susceptibility to HIV/AIDS among humans, and possibly, the observed interspecies differences in susceptibility to lentiviral infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442950     DOI: 10.4049/jimmunol.178.9.5668

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5.

Authors:  Heather A Pilch-Cooper; Scott F Sieg; Thomas J Hope; Ann Koons; Jean-Michel Escola; Robin Offord; Ronald S Veazey; Donald E Mosier; Brian Clagett; Kathy Medvik; Julie K Jadlowsky; Mark R Chance; Janna G Kiselar; James A Hoxie; Ronald G Collman; Nadeene E Riddick; Valentina Mercanti; Oliver Hartley; Michael M Lederman
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

2.  CCR5 promoter haplotype transcription complex characterization.

Authors:  Daifeng Jiang; Srinivas Mummidi; Sunil K Ahuja; Harry W Jarrett
Journal:  J Health Care Poor Underserved       Date:  2011

3.  Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.

Authors:  Olga Latinovic; Janaki Kuruppu; Charles Davis; Nhut Le; Alonso Heredia
Journal:  Clin Med Ther       Date:  2009

4.  Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection.

Authors:  Max W Richardson; Julie Jadlowsky; Chuka A Didigu; Robert W Doms; James L Riley
Journal:  J Immunol       Date:  2012-09-17       Impact factor: 5.422

5.  CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.

Authors:  Jose F Camargo; Marlon P Quinones; Srinivas Mummidi; Sowmya Srinivas; Alvaro A Gaitan; Kazi Begum; Fabio Jimenez; Scott VanCompernolle; Derya Unutmaz; Seema S Ahuja; Sunil K Ahuja
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

6.  Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor.

Authors:  German G Gornalusse; Srinivas Mummidi; Alvaro A Gaitan; Fabio Jimenez; Veron Ramsuran; Anabela Picton; Kristen Rogers; Muthu Saravanan Manoharan; Nymisha Avadhanam; Krishna K Murthy; Hernan Martinez; Angela Molano Murillo; Zoya A Chykarenko; Richard Hutt; Demetre Daskalakis; Ludmila Shostakovich-Koretskaya; Salim Abdool Karim; Jeffrey N Martin; Steven G Deeks; Frederick Hecht; Elizabeth Sinclair; Robert A Clark; Jason Okulicz; Fred T Valentine; Neil Martinson; Caroline Tanya Tiemessen; Thumbi Ndung'u; Peter W Hunt; Weijing He; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-11       Impact factor: 11.205

7.  Low levels of SIV infection in sooty mangabey central memory CD⁴⁺ T cells are associated with limited CCR5 expression.

Authors:  Mirko Paiardini; Barbara Cervasi; Elane Reyes-Aviles; Luca Micci; Alexandra M Ortiz; Ann Chahroudi; Carol Vinton; Shari N Gordon; Steven E Bosinger; Nicholas Francella; Paul L Hallberg; Elizabeth Cramer; Timothy Schlub; Ming Liang Chan; Nadeene E Riddick; Ronald G Collman; Cristian Apetrei; Ivona Pandrea; James Else; Jan Munch; Frank Kirchhoff; Miles P Davenport; Jason M Brenchley; Guido Silvestri
Journal:  Nat Med       Date:  2011-06-26       Impact factor: 53.440

8.  Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors.

Authors:  Rutger J Wierda; Hedwich F Kuipers; Marja C J A van Eggermond; Anne Benard; Jan C van Leeuwen; Silvia Carluccio; Sacha B Geutskens; J Wouter Jukema; Victor E Marquez; Paul H A Quax; Peter J van den Elsen
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

9.  Decreased plasticity of coreceptor use by CD4-independent SIV Envs that emerge in vivo.

Authors:  Nicholas Francella; Sarah T C Elliott; Yanjie Yi; Sarah E Gwyn; Alexandra M Ortiz; Bing Li; Guido Silvestri; Mirko Paiardini; Cynthia A Derdeyn; Ronald G Collman
Journal:  Retrovirology       Date:  2013-11-12       Impact factor: 4.602

10.  Genetic and Epigenetic Regulation of CCR5 Transcription.

Authors:  Rutger J Wierda; Peter J van den Elsen
Journal:  Biology (Basel)       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.